Pharmafile Logo

Webinar: Understanding the patient journey in China

March 31, 2015 | China, healthcare 

The Chinese healthcare market is experiencing a period of great change. Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and considers the possible implications for market researchers.

As the affluent middle-class continues to grow and healthcare reforms look set to affect the way that patients access treatment, the Chinese healthcare market is experiencing a period of great change.

Now more than ever,the researcher needs to ensure that they have a full understanding of how these developments will impact the market.

View our latest webinar where, utilising local knowledge and detailed case studies, we will examine the current Chinese healthcare market, discuss the likely impact of the government’s planned healthcare reforms on the patient journey and consider the possible implications for market researchers.Benefits of attending:

  • Gain a deeper understanding of the changing patient journey in China
  • Identify the opportunities and challenges associated with the healthcare reforms
  • Learn how to ensure that your market research in China continues to answer the business objectives

To view this webinar please visit http://bit.ly/1EXWHL4 

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Free Thinking: Behavioural economics

Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?

Article: The Colombia Conundrum

Published in eye for pharma 30 January by Marc Yates

Ageing in China: The Implications for Healthcare

Published in eye for pharma 12 December by Marc Yates

Exploring MINT: Part 4 – Turkey

In the fourth and final of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in...

Getting to grips with Russia’s healthcare market

As a non-Russian, trying to understand the complexities of the multiple overlapping levels of Russia’s healthcare system can be baffling at times. Information is often inaccessible or data simply doesn't...

Exploring MINT: Part 3 – Nigeria

In the third of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Nigeria.

Exploring MINT: Part 2 – Indonesia

In the second of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Indonesia, with...

Free Thinking: Leveraging the ASEAN Market

If you can only research one ASEAN market, which one do you choose?Our Free Thinking paper investigates the opportunities for pharma in ASEAN and outlines the factors you need to...

Free Thinking: Biosimilars: Friend or foe to healthcare?

Our Free Thinking white paper looks at the opportunities for biosimilars and the threats to innovator biologics.